severe semaglutide side effects for diabetes and obesity treatment 🚨 OZEMPIC USERS – KNOW

Once-weekly dosing: Tirzepatide is administered once a week by subcutaneous injection, which offers convenience and may improve treatment adherence

One of the main concerns for any glucose-lowering drug in T1D is the risk of hypoglycemia

prescribed drugs with approximately 25,954,066 prescriptions (ClinCalc DrugStats)

Many patients experience better sleep quality and reduced dependence on medications for chronic conditions

Additionally, both semaglutide and alcohol can lower blood glucose levels independently, creating a compounded risk of hypoglycemia (low blood sugar) in people with diabetes or prediabetes

Rybelsus, which also contains semaglutide, was the first oral GLP-1 medication FDA-approved in 2019 for adults with type 2 diabetes